Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Yakobson

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Life (Basel, Switzerland)|July 29, 2023
Radiotherapy-Induced Atrial Myxoma: A Case Report and Literature ReviewWalid Shalata, Ismaell Massalha, Shlomo Yaron Ishay, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Metabolic Activity Assessment by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID-19 VaccinationWalid Shalata, Daniel Levin, Janna Fridman, et al.
Journal of Personalized Medicine|September 28, 2023
Carpal Tunnel Syndrome Associated with Immune Checkpoint InhibitorsAlexander Yakobson, Keren Rouvinov, Aharon Y Cohen, et al.
Medicina (Kaunas, Lithuania)|November 25, 2023
Tolerated Re-Challenge of Immunotherapy in a Patient with ICI Associated Myocarditis: A Case Report and Literature ReviewWalid Shalata, Zoé Gabrielle Attal, Rajeh Shhadi, et al.
Cancers|November 11, 2022
A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint InhibitorsWalid Shalata, Sarah Weissmann, Sapir Itzhaki Gabay, et al.
Cancer Medicine|April 3, 2023
Avelumab for the treatment of locally advanced or metastatic Merkel cell carcinoma-A multicenter real-world experience in IsraelItamar Averbuch, Ronen Stoff, Mor Miodovnik, et al.
Biomedicines|September 28, 2023
Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung CancerWalid Shalata, Alexander Yakobson, Yulia Dudnik, et al.
Journal of Clinical Medicine|March 17, 2025
Real-World Data on Osimertinib-Associated Cardiac ToxicityAbed Agbarya, Ari Raphael, Hadas Gantz Sorotsky, et al.
Medicina (Kaunas, Lithuania)|August 29, 2024
Adverse Events in Osimertinib Treatment for EGFR-Mutated Non-Small-Cell Lung Cancer: Unveiling Rare Life-Threatening MyelosuppressionWalid Shalata, Ashraf Abu Jama, Yulia Dudnik, et al.
Journal of Personalized Medicine|November 25, 2023
Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World ExperienceKeren Rouvinov, Gal Mazor, Ella Kozlener, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Life (Basel, Switzerland)|July 29, 2023
Radiotherapy-Induced Atrial Myxoma: A Case Report and Literature ReviewWalid Shalata, Ismaell Massalha, Shlomo Yaron Ishay, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Metabolic Activity Assessment by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID-19 VaccinationWalid Shalata, Daniel Levin, Janna Fridman, et al.
Journal of Personalized Medicine|September 28, 2023
Carpal Tunnel Syndrome Associated with Immune Checkpoint InhibitorsAlexander Yakobson, Keren Rouvinov, Aharon Y Cohen, et al.
Medicina (Kaunas, Lithuania)|November 25, 2023
Tolerated Re-Challenge of Immunotherapy in a Patient with ICI Associated Myocarditis: A Case Report and Literature ReviewWalid Shalata, Zoé Gabrielle Attal, Rajeh Shhadi, et al.
Cancers|November 11, 2022
A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint InhibitorsWalid Shalata, Sarah Weissmann, Sapir Itzhaki Gabay, et al.
Cancer Medicine|April 3, 2023
Avelumab for the treatment of locally advanced or metastatic Merkel cell carcinoma-A multicenter real-world experience in IsraelItamar Averbuch, Ronen Stoff, Mor Miodovnik, et al.
Biomedicines|September 28, 2023
Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung CancerWalid Shalata, Alexander Yakobson, Yulia Dudnik, et al.
Journal of Clinical Medicine|March 17, 2025
Real-World Data on Osimertinib-Associated Cardiac ToxicityAbed Agbarya, Ari Raphael, Hadas Gantz Sorotsky, et al.
Medicina (Kaunas, Lithuania)|August 29, 2024
Adverse Events in Osimertinib Treatment for EGFR-Mutated Non-Small-Cell Lung Cancer: Unveiling Rare Life-Threatening MyelosuppressionWalid Shalata, Ashraf Abu Jama, Yulia Dudnik, et al.
Journal of Personalized Medicine|November 25, 2023
Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World ExperienceKeren Rouvinov, Gal Mazor, Ella Kozlener, et al.
Pageof 7